SQ

Sonia Quaratino

EVP, Chief Medical Officer

Innate Pharma


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Innate Pharma
Industry
research
Employees
200.0
Seniority
C suite
Annual Revenue
56754000.0

Technologies

Outlook Microsoft Office 365 Vimeo Google Analytics reCAPTCHA GoToWebinar Google Tag Manager Mobile Friendly BugHerd Google Font API Remote AI Micro

Keywords

biotechnologies antibodies immunotherapy oncology biotechnology: biological products (no diagnostic substances) health care biotechnology research innate pharma biotech nk cells therapeutic antibodies cancer drugs antag nk cell engagers adcs monoclonal antibodies clinical-stage immune system pipeline iph6501 iph6101 iph6401 iph62 iph4502 lacutamab monalizumab anti-kir3dl2 nkg2a solid tumors hemostatic malignancies autoimmune diseases cd20 non-hodgkin's lymphoma cutaneus t cell lymphoma partnering biopharmaceutical companies astrazeneca sanofi research institutions first-in-class differentiated adcs strategic partnerships proprietary platform innovation scientific expertise natural killer cells therapeutic opportunities clinical trials research & development cancer patients drug candidates advanced therapies drug commercialization healthcare conference biotech company biotechnology cancer treatment innate immunity antibody engineering antibody drug conjugates hematologic malignancies precision medicine innovative therapies drug development collaborations patient-centric immune system modulation inflammatory diseases healthcare providers therapeutic pipeline scientific excellence global impact transformative treatments unmet medical needs oncology market immuno-oncology therapeutic innovation patient outcomes hospital & health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans